CTL Medical Corporation partners with G-21: 3 takeaways

Written by Mackenzie Garrity | July 12, 2017 | Print  |

Dallas-based CTL Medical signed a partnership agreement with G-21 to market G-21's bone cement, kyphoplasty and vertebroplasty technology.

Here are three takeaways:


1. Each of the cement kits comes in the form of a two component system composed of a liquid and powder. The kits offer providers safety assurance and control of mechanical properties during surgery.


2. CTL Medical President and CEO Daniel Chon said, "We intend to begin immediate distribution of the full line of acrylic-based bone cements for widespread procedures necessary for vertebrae consolidation and stabilization."


3. G-21 is an Italian-based biomaterials company that develops long-term implantable medical devices using raw materials.


More articles on devices:
ECA Medical Instruments' sterile-packed, disposable orthopedics kits see growing adoption: 4 key notes
Zimmer Biomet CEO David Dvorak exits after 10 years
DePuy Synthes releases single use kits for wrist fracture surgery: 5 key points

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months